| pubmed-article:2742290 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2742290 | lifeskim:mentions | umls-concept:C0027092 | lld:lifeskim |
| pubmed-article:2742290 | lifeskim:mentions | umls-concept:C0004259 | lld:lifeskim |
| pubmed-article:2742290 | lifeskim:mentions | umls-concept:C0010582 | lld:lifeskim |
| pubmed-article:2742290 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:2742290 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:2742290 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:2742290 | pubmed:dateCreated | 1989-8-3 | lld:pubmed |
| pubmed-article:2742290 | pubmed:abstractText | We evaluated the effectiveness of cycloplegics in the treatment of myopia. Patients were selected randomly and divided into three groups: Group 1 received atropine 1% eye drops every other night; Group 2 received cyclopentolate 1% eye drops every night; and Group 3 received normal saline eye drops every night. All the patients were rechecked every three months. The results were evaluated at the end of one year. Ninety-six patients were evaluated, 32 in each group. The mean myopic progression was -0.219 D in the atropine group, -0.578D in the cyclopentolate group, and -0.914D in the saline group. Analysis showed that atropine and cyclopentolate are effective in slowing the progression of myopia. The effect of atropine is better than that of cyclopentolate. | lld:pubmed |
| pubmed-article:2742290 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2742290 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2742290 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2742290 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2742290 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2742290 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2742290 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2742290 | pubmed:month | May | lld:pubmed |
| pubmed-article:2742290 | pubmed:issn | 0003-4886 | lld:pubmed |
| pubmed-article:2742290 | pubmed:author | pubmed-author:TanR SRS | lld:pubmed |
| pubmed-article:2742290 | pubmed:author | pubmed-author:LiuJ HJH | lld:pubmed |
| pubmed-article:2742290 | pubmed:author | pubmed-author:KaoS CSC | lld:pubmed |
| pubmed-article:2742290 | pubmed:author | pubmed-author:ShiaoC HCH | lld:pubmed |
| pubmed-article:2742290 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2742290 | pubmed:volume | 21 | lld:pubmed |
| pubmed-article:2742290 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2742290 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2742290 | pubmed:pagination | 180-2, 187 | lld:pubmed |
| pubmed-article:2742290 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2742290 | pubmed:meshHeading | pubmed-meshheading:2742290-... | lld:pubmed |
| pubmed-article:2742290 | pubmed:meshHeading | pubmed-meshheading:2742290-... | lld:pubmed |
| pubmed-article:2742290 | pubmed:meshHeading | pubmed-meshheading:2742290-... | lld:pubmed |
| pubmed-article:2742290 | pubmed:meshHeading | pubmed-meshheading:2742290-... | lld:pubmed |
| pubmed-article:2742290 | pubmed:meshHeading | pubmed-meshheading:2742290-... | lld:pubmed |
| pubmed-article:2742290 | pubmed:meshHeading | pubmed-meshheading:2742290-... | lld:pubmed |
| pubmed-article:2742290 | pubmed:meshHeading | pubmed-meshheading:2742290-... | lld:pubmed |
| pubmed-article:2742290 | pubmed:meshHeading | pubmed-meshheading:2742290-... | lld:pubmed |
| pubmed-article:2742290 | pubmed:meshHeading | pubmed-meshheading:2742290-... | lld:pubmed |
| pubmed-article:2742290 | pubmed:meshHeading | pubmed-meshheading:2742290-... | lld:pubmed |
| pubmed-article:2742290 | pubmed:meshHeading | pubmed-meshheading:2742290-... | lld:pubmed |
| pubmed-article:2742290 | pubmed:meshHeading | pubmed-meshheading:2742290-... | lld:pubmed |
| pubmed-article:2742290 | pubmed:meshHeading | pubmed-meshheading:2742290-... | lld:pubmed |
| pubmed-article:2742290 | pubmed:meshHeading | pubmed-meshheading:2742290-... | lld:pubmed |
| pubmed-article:2742290 | pubmed:meshHeading | pubmed-meshheading:2742290-... | lld:pubmed |
| pubmed-article:2742290 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2742290 | pubmed:articleTitle | Comparison of the effect of atropine and cyclopentolate on myopia. | lld:pubmed |
| pubmed-article:2742290 | pubmed:affiliation | Department of Ophthalmology, Veterans General Hospital, Yang-Ming Medical College, Taipei, Taiwan, Republic of China. | lld:pubmed |
| pubmed-article:2742290 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2742290 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:2742290 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:2742290 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2742290 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2742290 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2742290 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2742290 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2742290 | lld:pubmed |
